Cargando…
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
BACKGROUND: Liver transplantation (LT) has been validated widely all over the world as the curative treatment for hepatocellular carcinoma (HCC). Statins have been reported to prevent the progression of HCC. There are many factors that affect recurrence of HCC, but the precise role of statins is unk...
Autores principales: | Lee, Okjoo, Rhu, Jinsoo, Choi, Gyu-Seong, Kim, Jong Man, Kim, Kyunga, Joh, Jae-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994471/ https://www.ncbi.nlm.nih.gov/pubmed/35379768 http://dx.doi.org/10.12659/AOT.935604 |
Ejemplares similares
-
Impact of Graft Weight Change During Perfusion on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation
por: Kim, Jong Man, et al.
Publicado: (2021) -
Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
por: Rhu, Jinsoo, et al.
Publicado: (2018) -
Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation
por: Kim, Minjeong, et al.
Publicado: (2021) -
Early reoperation after adult living-donor liver transplantation is associated with poor survival
por: Lim, Manuel, et al.
Publicado: (2019) -
Comparison of liver regeneration in laparoscopic versus open right hemihepatectomy for adult living donor liver transplantation
por: Yang, Jaehun, et al.
Publicado: (2020)